Clinical Trial Update: DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study) [Phase 1]

View source ↗

Summary

A phase 1 imaging study by AstraZeneca and Royal Marsden Hospital evaluating dynamic contrast-enhanced CT/MRI in patients with solid tumours.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Cancer | Phase 1 | Status: COMPLETED